Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2)

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis

1994 • 1,695 citations

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α

1993 • 1,031 citations

Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Therapeutiques des Affections Inflammatoires du Tube Digestif (GETAID).

1989 • 833 citations

Construction and initial characterization of a mouse-human chimeric anti-TNF antibody

1993 • 714 citations

Tumour necrosis factor alpha in stool as a marker of intestinal inflammation

1992 • 700 citations

Repeated therapy with monoclonal antibody to tumour necrosis factor α (cA2) in patients with rheumatoid arthritis

1994 • 632 citations

Tumor necrosis factor α-producing cells in the intestinal mucosa of children with inflammatory bowel disease

1994 • 578 citations

Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine

1990 • 489 citations

A Placebo-Controlled, Double-Blind, Randomized Trial of Cyclosporine Therapy in Active Chronic Crohn's Disease

1989 • 380 citations

Low-Dose Cyclosporine for the Treatment of Crohn's Disease

1994 • 261 citations

Inflammatory granuloma formation is mediated by TNF-alpha-inducible intercellular adhesion molecule-1.

1994 • 137 citations

Soluble receptors for tumour necrosis factor: a putative marker of disease progression in HIV infection.

1993 • 85 citations

Plasma interleukin-2 and a soluble/shed interleukin-2 receptor in serum of patients with Crohn's disease. Effect of cyclosporin.

1990 • 78 citations

Soluble receptors for tumour necrosis factor

1993 • 63 citations

CD4 Antibody Treatment in Crohn's Disease

1992 • 17 citations